#FORTODAYFORTOMORROW
For today, for tomorrow
We know that type 2 diabetes mellitus is the beginning of a progressive and silent damage that leads to heart failure; for this reason we have prepared a material to see the change and inspect the heart.
For AstraZeneca it is very important to educate doctors, patients and the general population about the correct management of this serious disease. And remember that together we have many actions in our hands to combat and prevent this disease. Together we can change life with our daily actions!
NUMBERS IN THE WORLD *
463 million people
live with DIABETES in the world
200 million people
with CHRONIC KIDNEY
diseases in the world
17.7 million deaths
for CARDIOVASCULAR
diseases every year
40% of patients
with HEART FAILURE have
RENAL DISEASE
MATERIAL TO CONSULT *
MEDICAL EDUCATION
NUTRIPLANS FOR PATIENTS WITH DIABETES
Breakfasts, lunches, dinners and snacks between 1,200 to 2,000 calories are included. All made and reviewed by expert nutritionists. Remember that together we have many measures in our hands to fight and prevent this disease. Together we can change our life with our daily
actions!
INNOVATION IN TREATMENTS FOR TYPE 2 DIABETES
Diabetes is a disease characterized by high levels of glucose in the blood. Unfortunately it is a chronic disease; however, the patient can control it and avoid complications with proper treatment and care, achieving a better quality of life.
DAPAGLIFLOZIN VS SU DPP4 INHIBITOR and SGLT2 INHIBITOR
Learn about the differences between Dapagliflozin and other treatments and how they can help improve the lives of your patients. In this infographic you will find the difference between the use of Dapagliflozin vs other treatments. Diabetes is more than just glucose.
* References
https://www.idf.org/aboutdiabetes/what-is-diabetes/facts-figures.html. Revisión 28 de Mayo 2020 World Health Organization. WHO World Heart Day 2017: Scale up prevention of heart attack and stroke: World Health Organization; 2017 [cited 2018 Jul 25]. Disponible en: http://www.who.int/cardiovascular_diseases/world-heart-day-2017/en/.
Ojo A. Addressing the global burden of chronic kidney disease through clinical and translational research. Trans Am Clin Climatol Assoc 2014; 125:229-43; discussion 243-6
International Diabetes Foundation. Diabetes Atlas Eighth Edition 2017 (p43). Available at https://www.idf.org/e-library/epidemiology-research/diabetes-atlas.html
Our products
In this section you will find the latest information on each drug in the AstraZeneca Renal and Metabolic Line.
